Evidence map›Paper›PMID 36781883›Full record

ArticleNature communications2023

APOBEC3B drives PKR-mediated translation shutdown and protects stress granules in response to viral infection.

Lavanya Manjunath, Sunwoo Oh, Pedro Ortega, Alexis Bouin, Elodie Bournique, Ambrocio Sanchez, Pia Møller Martensen, Ashley A Auerbach, Jordan T Becker, Marcus Seldin and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. A CRISPR-Cas9 knockout screening identifies IRF2 as a key driver of OAS3/RNase L-mediated RNA decay during viral infection.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Lavanya Manjunath *Department of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA.ORCID 0000-0003-1898-3570
Sunwoo Oh *Department of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA.ORCID 0000-0001-9205-4660
Pedro OrtegaDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA.ORCID 0000-0003-4216-3695
Alexis BouinCenter for Virus Research, University of California Irvine, Irvine, CA, USA.
Elodie BourniqueDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA.ORCID 0000-0003-0196-7996
Ambrocio SanchezDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA.ORCID 0000-0003-1462-1767
Pia Møller MartensenDepartment of Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark.
Ashley A AuerbachDepartment of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.
Jordan T BeckerInstitute for Molecular Virology, University of Minnesota - Twin Cities, Minneapolis, MN, USA.ORCID 0000-0002-0239-5443
Marcus SeldinDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA.
Reuben S HarrisDepartment of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.
Bert L SemlerCenter for Virus Research, University of California Irvine, Irvine, CA, USA.ORCID 0000-0002-2424-5155
Rémi BuissonDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA. rbuisson@uci.edu.ORCID 0000-0002-7196-8209
University of California, Irvine · USUniversity of Minnesota · USAarhus University · DKHoward Hughes Medical Institute · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
PROJECT 3 – BIOLOGY OF DNA DEAMINASES IN CANCERP01CA234228 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Michael Allen Carpenter · 2019 to 2026
$14.5M
APOBEC3 Proteins in HIV RestrictionR37AI064046 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HARRIS, REUBEN S · 2015 to 2024
$4.2M
Integrative approaches to dissection of endocrine communicationDP1DK130640 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI SELDIN, MARCUS MICHAEL · 2021 to 2025
$3.2M
Minnesota Training Program in VirologyT32AI083196 · NIAID · UNIVERSITY OF MINNESOTA · PI Louis M Mansky · 2010 to 2026
$3.2M
Molecular Mechanisms of APOBEC-Induced Mutagenesis in CancerR37CA252081 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Remi Buisson · 2021 to 2026
$2.5M
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cellsR01AI155962 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI GERSHON, PAUL D, SEMLER, BERT L · 2021 to 2025
$2.3M
TARGETING APOBEC3A-EXPRESSING CANCER CELLS WITH ATR INHIBITORSR00CA212154 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI BUISSON, REMI · 2018 to 2020
$747k
APOBEC PROTEINS AND RIBOVIRAL RESTRICTIONF32AI147813 · NIAID · UNIVERSITY OF MINNESOTA · PI BECKER, JORDAN T · 2019 to 2021
$192k
NCI NIH HHS P01 CA234228NCI NIH HHS P30 CA062203NCI NIH HHS R00 CA212154NCI NIH HHS R37 CA252081NIAID NIH HHS F32 AI147813NIAID NIH HHS R01 AI155962NIAID NIH HHS R37 AI064046NIAID NIH HHS T32 AI083196NIDDK NIH HHS DP1 DK130640
6 · The paper itself

Abstract

Double-stranded RNA produced during viral replication and transcription activates both protein kinase R (PKR) and ribonuclease L (RNase L), which limits viral gene expression and replication through host shutoff of translation. In this study, we find that APOBEC3B forms a complex with PABPC1 to stimulate PKR and counterbalances the PKR-suppressing activity of ADAR1 in response to infection by many types of viruses. This leads to translational blockage and the formation of stress granules. Furthermore, we show that APOBEC3B localizes to stress granules through the interaction with PABPC1. APOBEC3B facilitates the formation of protein-RNA condensates with stress granule assembly factor (G3BP1) by protecting mRNA associated with stress granules from RNAse L-induced RNA cleavage during viral infection. These results not only reveal that APOBEC3B is a key regulator of different steps of the innate immune response throughout viral infection but also highlight an alternative mechanism by which APOBEC3B can impact virus replication without editing viral genomes.

Indexed as

Stress GranulesVirus DiseasesCytidine DeaminaseCytoplasmic GranulesDNA HelicaseseIF-2 KinaseHumansMinor Histocompatibility AntigensPoly-ADP-Ribose Binding ProteinsProtein KinasesRNA HelicasesRNA Recognition Motif ProteinsVirus ReplicationAPOBEC3B protein, humanCytidine DeaminaseDNA HelicaseseIF-2 KinaseG3BP1 protein, humanMinor Histocompatibility AntigensPoly-ADP-Ribose Binding ProteinsProtein KinasesRNA HelicasesRNA Recognition Motif Proteins

Identifiers

PMID36781883
PMCPMC9925369
OpenAlexW4320710334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.